Align Technology | ALGN - Assets


Align Technology reported $6.52B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
3M USD 39.53B 4.6B Sep/2026
Align Technology USD 6.52B 103.03M Sep/2026
Becton, Dickinson and Co. USD 50.79B 60M Sep/2026
Bruker USD 5.83B 224.6M Sep/2026
Cardinal Health USD 59.54B 2.24B Sep/2026
Charles River Laboratories USD 7.45B 80.64M Sep/2026
Cooper Companies USD 12.67B 191.1M Jun/2026
CVS Health USD 258.08B 4.31B Sep/2026
Danaher USD 93.28B 914M Sep/2026
Dentsply International USD 5.19B 14M Sep/2026
Dexcom USD 6.24B 216.5M Sep/2026
Henry Schein USD 11.51B 129M Sep/2026
Idexx Laboratories USD 3.71B 264.77M Sep/2026
Insulet USD 3.42B 250M Sep/2026
Integra LifeSciences USD 3.51B 55.69M Sep/2026
IQVIA Holdings USD 30.47B 593M Sep/2026
McKesson USD 92.32B 3.99B Sep/2026
Mettler Toledo International USD 3.7B 24.53M Sep/2026
Revvity USD 11.49B 555.49M Sep/2026
Solventum Corp USD 14.16B 78M Sep/2026
Stryker USD 47.25B 683M Sep/2026
Teleflex USD 6.35B 438.92M Sep/2026
Thermo Fisher Scientific USD 114.23B 1.06B Sep/2026
Veeva Systems USD 9.06B 69.33M Jun/2026
Waters USD 24.12B 636M Sep/2026
Zimmer Biomet Holdings USD 23.54B 740.8M Sep/2026
Zoetis USD 15.09B 11M Sep/2026